ASP Isotopes Inc. (ASPI) SEC Filings & Earnings Calls

Regulatory and operational risks in South Africa; development-stage technology not yet applied to U-235 enrichment.

“The company has not applied its enrichment technologies to the enrichment of U-235, nor received permission or regulatory approval to conduct testing of our enrichment technologies on U-235, except for the activities contemplated by the services contract with Necsa.” · word for word

Merger completion risk and financing uncertainty.

“Risks related to merger approval, financing, and regulatory approvals.”

Early stage; no current revenue or EBITDA; execution risk on multiple business lines.

“Transitioning from building to producing; no current revenue or EBITDA disclosed.”

Execution risk in commissioning and ramp-up of Phase 1 helium plant.

“Commissioning phase just started; first commercial shipments expected in September 2026.”

Phase 2 funding and construction risk; $750M debt funding not yet secured.

“Intend to pursue up to $750 million of senior debt funding, subject to negotiation and execution of binding definitive agreements.” · word for word

Customer concentration risk: only 15% of Phase 1 helium under contract.

“15% of Phase 1 liquid helium under take-or-pay contracts.”

Debt restructuring may indicate financial stress or refinancing needs.

“Amendment to credit agreement with Standard Bank of South Africa.”

Regulatory and environmental approval risk for proposed facility in Namibia.

“Any future development would be subject to technical, commercial, environmental and regulatory review and approvals.” · word for word

No final investment decision; project may not proceed.

“The evaluation remains at an early stage, and no final investment decision has been made.” · word for word

Pre-revenue on core isotopes

“We have not generated any revenue from the sale of our enriched isotopes as of June 30, 2026.” · word for word

Phase 2 Virginia Gas Project capital requirement

“Phase 2 of the Virginia Gas Project requires a significant amount of capital and is currently estimated to cost approximately $1.16 billion” · word for word

Regulatory approval for uranium enrichment

“If we receive permits and licenses to enrich U-235 (which in itself is highly uncertain), we do not expect U-235 to be commercially available for at least several years, if ever.” · word for word

Phase 1 completion still subject to construction and regulatory risks; commercial production targeted for Q3 2026.

“Phase 1 commercial operations remain targeted for completion in the third quarter of 2026.”

Geopolitical issues constrict helium supply but also create opportunity; South Africa energy challenges may affect operations.

“Geopolitical issues have greatly constricted the supply of this critical material; South Africa's domestic energy situation has proved challenging.” · word for word

Stable isotope division delays due to OEM equipment issues; risk of further delays impacting commercial shipments.

“While the delays in our stable isotope division have been frustrating, these delays are attributable primarily to performance issues with certain equipment provided by our former OEM suppliers.” · word for word

Reverse merger and public listing of Renergen subject to closing conditions; execution risk.

“Renergen, through the planned reverse merger... is expected to become a Nasdaq-listed company upon the closing of the reverse merger.”

Helium production start expected before Sep 2026; any delay could impact revenue guidance.

“We expect to commence helium production at Renergen prior to September 30, 2026.” · word for word

EBITDA targets are aspirational and non-GAAP; no reconciliation provided; execution risk.

“We have not provided a reconciliation between our targets for EBITDA and net income (loss)...” · word for word

No material risk signals; filing is routine investor relations activity.

“No financial or operational disclosures.”

Research stage; no immediate revenue; technology development risk.

“agreement focuses on collecting fundamental physicochemical data; no commercial production yet.” · word for word

Discontinued operations indicate exit from construction services; no new risk beyond prior disclosure.

“deconsolidation of Skyline Builders Group completed March 29, 2026; retained 8.6% stake.”

Significant dilution from issuance of 23.16M new shares; remaining $110.7M notes still outstanding.

“23,160,682 newly issued shares; $110.7M notes remain outstanding”

Complex merger structure with dual-class stock; execution and integration risks; shareholder approval required.

“Merger subject to conditions; dual-class structure may create governance concerns.”

Merger completion risk and regulatory approvals.

“Proposed merger subject to closing conditions and regulatory approvals.”

Phase 1 production and offtake completion risk; Phase 2 financing still conditional.

“Phase 1 commercial production expected Q3 2026; Phase 2 debt financing conditional.”

Remaining stages still require engineering enhancements; commercial production timeline subject to execution.

“same engineering enhancements are expected to be implemented to the remaining stages” · word for word

No revenue from enriched isotopes yet

“we have not generated any revenue from the sale of our enriched isotopes as of March 31, 2026” · word for word

Regulatory and licensing risk for uranium enrichment

“If we receive permits and licenses to enrich U-235 (which in itself is highly uncertain), we do not expect U-235 to be commercially available for at least several years, if ever” · word for word

Phase 2 capex risk ($1.16B)

“Phase 2 of the Virginia Gas Project requires a significant amount of capital and is currently estimated to cost approximately $1.16 billion” · word for word

Dependence on TerraPower and DFC funding

“the up to $500 million of senior secured debt provided by the DFC, which has been conditionally approved” · word for word

Foreign exchange risk (South Africa)

“Foreign exchange transaction loss (3,725 ) (61 ) (3,664 )” · word for word

No new risks identified; filing is boilerplate.

MOU is non-binding; no guaranteed revenue; execution risk on enrichment facilities.

“Non-binding MOU; subject to technical and economic assessment.”

Dependence on external feedstock for Carbon-14 production; delivery delays could impact commercial shipments.

“final feedstock delivery from the supplier is expected imminently; contingent on timely receipt of feedstock from Canadian supplier.” · word for word

Operational risk from external infrastructure events; laser damage in South Africa caused production halt.

“power surge in eastern Pretoria damaged one of three lasers, causing production halt.”

No Commercial Production

“We currently have no sales attributable to enriched isotopes.” · word for word

Technology Unproven for Uranium

“In the period since our inception to date, we have not applied our enrichment technologies to the enrichment of U-235.” · word for word

Massive Capital Requirement

“From our latest cost estimate we anticipate we will need to incur at least approximately $1.16 billion in costs to complete Phase 2 of the Virginia Gas Project.” · word for word

Regulatory Hurdles

“Multiple regulatory agencies need to provide approvals to allow us to proceed with the research and development necessary to show proof of concept to the market.” · word for word

Helium supply disruption due to Strait of Hormuz closure and Qatar facility damage; potential upward pricing pressure.

“closure of the Strait of Hormuz has put immediate and considerable pressure on supply; Ras Laffan facility damaged” · word for word

Development stage company with no current revenue; reliance on regulatory support and partnerships.

“Company is development stage; forward-looking statements about future plans.”

Early-stage biotech investment carries high risk; no guarantee of product success or supply agreement materialization.

“Opeongo is a biotechnology company developing novel therapeutics; early stage.” · word for word

Drilling schedule adjustments due to deeper targets, water management, and historical mining impacts.

“Drilling activities have experienced schedule adjustments due to deeper-than-anticipated target depths, water management requirements, land access coordination, and localized impacts from historical underground mining.” · word for word

Integration risk from Renergen acquisition

“New executives from acquired company; integration may pose challenges.”

Integration risk of Renergen acquisition

“Cross-border acquisition; South African operations; stock consideration dilutes existing shareholders”

Dilution from stock issuance

“14.27M shares issued as consideration”

Cross-border regulatory and execution risk.

“South African Takeover Regulation Panel compliance certificate; cross-border implementation”

Integration risk and potential dilution from share issuance.

“Renergen shareholders will receive 0.09196 new ASP Isotopes shares for each Renergen share” · word for word

CEO transition due to medical leave; founder returns.

“Mr. Mann’s medical leave of absence” · word for word

Temporary leave of absence of founder/CEO may have caused uncertainty; return provides stability.

“Paul Mann to return from temporary leave of absence as Executive Chairman and Chief Executive Officer.” · word for word

Regulatory approval risk; extension needed for South African Reserve Bank approval

“implementation of the Scheme remained subject to the approval of the Financial Surveillance Department of the South African Reserve Bank” · word for word

CEO health-related absence

“Effective October 1, 2025, Paul was appointed our Executive Chairman and began taking a temporary leave of absence from his Chief Executive Officer duties for health reasons.” · word for word

Pre-revenue status for core isotope business

“We have not generated any revenue from the sale of our enriched isotopes” · word for word

Significant operating losses and cash burn

“Net loss before income tax expense $ (96,414,046 ) for the nine months ended September 30, 2025”

Dependence on regulatory approvals for uranium enrichment

“Subject to the receipt of funding and all required permits and licenses to begin enrichment of U-235 in South Africa” · word for word

Convertible note dilution risk

“These convertible promissory notes automatically convert into common shares upon Quantum Leap Energy’s closing of an IPO or other qualifying public transaction at 80% of the share price” · word for word

Renergen acquisition conditions and debt

“the Renergen Lenders agree not to proceed in foreclosing on outstanding debt due by those subsidiaries, as a result of any breach of covenants, event of default or otherwise, prior to July 31, 2027” · word for word

Potential dilution from convertible notes; terms not fully disclosed.

“Form of Convertible Note Purchase Agreement (including Form of Convertible Promissory QLE Note)” · word for word

Convertible notes may dilute equity if converted; subsidiary-level debt.

“QLE convertible promissory notes offering.”

Regulatory and operational risks in nuclear industry; early stage.

“Early engagement with regulators; no revenue or production timeline.”